NCT00338052 - Study of Bleeding With Extended Administration of an Oral Contraceptive | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Contraception

Interventions

DRUG

Norethindrone 1 mg / ethinyl estradiol 20 mcg

Trial Locations (23)

19114

Warner Chilcott Investigational Site, Philadelphia

23456

Warner Chilcott Investigational Site, Virginia Beach

27103

Warner Chilcott Investigational Site, Winston-Salem

28562

Warner Chilcott Investigational Site, New Bern

29607

Warner Chilcott Investigational Site, Greenville

30034

Warner Chilcott Investigational Site, Decatur

30075

Warner Chilcott Investigational Site, Roswell

33143

Warner Chilcott Investigational Site, Miami

33186

Warner Chilcott Investigational Site, Miami

33401

Warner Chilcott Investigational Site, West Palm Beach

33437

Warner Chilcott Investigational Site, Boynton Beach

34748

Warner Chilcott Investigational Site, Leesburg

40291

Warner Chilcott Investigational Site, Louisville

40509

Warner Chilcott Investigational Site, Lexington

61615

Warner Chilcott Investigational Site, Peoria

84017

Warner Chilcott Investigational Site, Salt Lake City

84062

Warner Chilcott Investigational Site, Pleasant Grove

84070

Warner Chilcott Investigational Site, Sandy City

85031

Warner Chilcott Investigational Site, Phoenix

85050

Warner Chilcott Investigational Site, Phoenix

85283

Warner Chilcott Investigational Site, Tempe

95608

Warner Chilcott Investigational Site, Carmichael

98105

Warner Chilcott Investigational Site, Seattle